FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2134495718> ?p ?o ?g. }

• W2134495718 endingPage "494" @default.
• W2134495718 startingPage "489" @default.
• W2134495718 abstract "Paclitaxel (Taxol) is a new antineoplastic agent derived from the bark of the western yew, Taxus brevifolia, with important activity against several tumors such as ovarian cancer, breast cancer, lung cancer and head and neck cancer. Because it promotes microtubule assembly, neuropathy occurs as one of its toxic side effects. Our purpose was to evaluate the incidence, severity, dose-dependency and reversibility of paclitaxel-induced neuropathy.We prospectively studied 27 patients treated with single-agent paclitaxel at three dose levels. Paclitaxel was administered by 3-hour intravenous infusion every three weeks in all patients, and if possible, all were evaluated neurologically before paclitaxel, after every other cycle and after discontinuation of therapy. We used a standardized questionnaire and neurologic examination with emphasis on neuropathic symptoms and signs. The severity of symptoms and signs was scored. Quantitatively, vibratory perception threshold (vibrameter) and grip strength (dynamometer) were measured.Six, 14 and seven patients were treated with 135 mg/m2, 175 mg/m2 and 250-300 mg/m2, respectively. Neuropathic symptoms occurred in 50%, 79% and 100%, neuropathic signs in 83%, 86% and 100%, and dose-limiting neurotoxicity in 0%, 21% and 71% of patients, respectively. Neurotoxicity progressed with higher cumulative dose and was more pronounced with higher dose per course. Paclitaxel-induced neuropathy was predominantly sensory in character, though minor motor signs were present. Follow-up data of 12 patients after discontinuation of paclitaxel therapy showed that paclitaxel-induced neuropathy is at least partially reversible.Paclitaxel-induced neuropathy is a dose-dependent phenomenon, occurring with higher cumulative dose and higher dose per cycle. Using 3-weekly 3-hour infusions of paclitaxel, dose-limiting neurotoxicity can be expected in patients treated with 250 mg/m2 or more each cycle." @default.
• W2134495718 created "2016-06-24" @default.
• W2134495718 creator A5007067879 @default.
• W2134495718 creator A5022161944 @default.
• W2134495718 creator A5049939318 @default.
• W2134495718 creator A5062035206 @default.
• W2134495718 creator A5089685346 @default.
• W2134495718 date "1995-05-01" @default.
• W2134495718 modified "2023-10-10" @default.
• W2134495718 title "Paclitaxel-induced neuropathy" @default.
• W2134495718 cites W1956546108 @default.
• W2134495718 cites W1966433003 @default.
• W2134495718 cites W1981534406 @default.
• W2134495718 cites W1987527812 @default.
• W2134495718 cites W2001797064 @default.
• W2134495718 cites W2008793220 @default.
• W2134495718 cites W2011447881 @default.
• W2134495718 cites W2017480334 @default.
• W2134495718 cites W2019263397 @default.
• W2134495718 cites W2019823033 @default.
• W2134495718 cites W2020447870 @default.
• W2134495718 cites W2037605675 @default.
• W2134495718 cites W2049209075 @default.
• W2134495718 cites W2057157978 @default.
• W2134495718 cites W2058979413 @default.
• W2134495718 cites W2067299834 @default.
• W2134495718 cites W2081406767 @default.
• W2134495718 cites W2084092457 @default.
• W2134495718 cites W2096102243 @default.
• W2134495718 cites W2117995467 @default.
• W2134495718 cites W2145555831 @default.
• W2134495718 cites W2165982968 @default.
• W2134495718 cites W2203588727 @default.
• W2134495718 cites W2227235589 @default.
• W2134495718 cites W2262251960 @default.
• W2134495718 cites W4255152173 @default.
• W2134495718 doi "https://doi.org/10.1093/oxfordjournals.annonc.a059220" @default.
• W2134495718 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7669713" @default.
• W2134495718 hasPublicationYear "1995" @default.
• W2134495718 type Work @default.
• W2134495718 sameAs 2134495718 @default.
• W2134495718 citedByCount "228" @default.
• W2134495718 countsByYear W21344957182012 @default.
• W2134495718 countsByYear W21344957182013 @default.
• W2134495718 countsByYear W21344957182014 @default.
• W2134495718 countsByYear W21344957182015 @default.
• W2134495718 countsByYear W21344957182016 @default.
• W2134495718 countsByYear W21344957182017 @default.
• W2134495718 countsByYear W21344957182018 @default.
• W2134495718 countsByYear W21344957182019 @default.
• W2134495718 countsByYear W21344957182020 @default.
• W2134495718 countsByYear W21344957182021 @default.
• W2134495718 countsByYear W21344957182022 @default.
• W2134495718 countsByYear W21344957182023 @default.
• W2134495718 crossrefType "journal-article" @default.
• W2134495718 hasAuthorship W2134495718A5007067879 @default.
• W2134495718 hasAuthorship W2134495718A5022161944 @default.
• W2134495718 hasAuthorship W2134495718A5049939318 @default.
• W2134495718 hasAuthorship W2134495718A5062035206 @default.
• W2134495718 hasAuthorship W2134495718A5089685346 @default.
• W2134495718 hasBestOaLocation W21344957181 @default.
• W2134495718 hasConcept C121608353 @default.
• W2134495718 hasConcept C126322002 @default.
• W2134495718 hasConcept C134018914 @default.
• W2134495718 hasConcept C141071460 @default.
• W2134495718 hasConcept C151032500 @default.
• W2134495718 hasConcept C2776694085 @default.
• W2134495718 hasConcept C2777107010 @default.
• W2134495718 hasConcept C2777292972 @default.
• W2134495718 hasConcept C2778715236 @default.
• W2134495718 hasConcept C2779491297 @default.
• W2134495718 hasConcept C2779901536 @default.
• W2134495718 hasConcept C29730261 @default.
• W2134495718 hasConcept C42219234 @default.
• W2134495718 hasConcept C530470458 @default.
• W2134495718 hasConcept C555293320 @default.
• W2134495718 hasConcept C71924100 @default.
• W2134495718 hasConcept C90924648 @default.
• W2134495718 hasConceptScore W2134495718C121608353 @default.
• W2134495718 hasConceptScore W2134495718C126322002 @default.
• W2134495718 hasConceptScore W2134495718C134018914 @default.
• W2134495718 hasConceptScore W2134495718C141071460 @default.
• W2134495718 hasConceptScore W2134495718C151032500 @default.
• W2134495718 hasConceptScore W2134495718C2776694085 @default.
• W2134495718 hasConceptScore W2134495718C2777107010 @default.
• W2134495718 hasConceptScore W2134495718C2777292972 @default.
• W2134495718 hasConceptScore W2134495718C2778715236 @default.
• W2134495718 hasConceptScore W2134495718C2779491297 @default.
• W2134495718 hasConceptScore W2134495718C2779901536 @default.
• W2134495718 hasConceptScore W2134495718C29730261 @default.
• W2134495718 hasConceptScore W2134495718C42219234 @default.
• W2134495718 hasConceptScore W2134495718C530470458 @default.
• W2134495718 hasConceptScore W2134495718C555293320 @default.
• W2134495718 hasConceptScore W2134495718C71924100 @default.
• W2134495718 hasConceptScore W2134495718C90924648 @default.
• W2134495718 hasIssue "5" @default.
• W2134495718 hasLocation W21344957181 @default.
• W2134495718 hasLocation W21344957182 @default.

• next